Frost: Awareness, Standardization Initiatives to Drive Surgical Infection Control Market
June 12, 2007 // Published as a news service by IHS
| |
| Medical Device Documents |
IHS is a leading provider of online access to medical device standards collections.
Complete this form for a free quote. |
|
Growing awareness of nosocomial infections and their multi-level effects will drive the European surgical infection control market.
According to Frost & Sullivan, ongoing initiatives to implement standardized regulations on a pan-European basis will ensure consistency in products and prices across Europe.
Recent analysis from Frost & Sullivan found that the European surgical infection control market earned revenues of $159.4 million in 2006, with estimates to reach $244.1 in 2013.
"Market growth will be spurred by the importance given to awareness campaigns about nosocomial infections across Europe," said Frost & Sullivan research associate Sabita Ramachandran.
"Rising awareness in public health and political arenas, as well as among the general public will positively influence market expansion."
Analysts said in addition to limited awareness of nosocomial infections, a brand-oriented landscape, the lack of uniform pan-European regulations and the need to maximize product efficacy are posing challenges to market growth.
Global and pan-European brands dominate the competitive landscape, analysts said. However, market penetration will not be easy to undertake due to the strong presence of tier one participants. Product classification also varies across some countries due to the lack of uniform pan-European regulations, thereby making it harder for smaller companies to license their products across Europe.
"In this highly competitive market, it is important to distinguish offerings based on factors of maximum product efficacy," said Ramachandran. "Effective and accelerated antimicrobial action of products in combination with superior after-sales services will help companies achieve success."
Source: Frost & Sullivan.